News Zoetis Inc.

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:03 2026-01-20 pm EST			5-day change	1st Jan Change
123.24 ^USD	-1.13%		-1.11%	-2.05%

Jan. 12	Zoetis CEO on Animal Health, Vaccines and Beef Prices	MT
Jan. 12	Zoetis Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM

Jan. 12	Zoetis CEO on Animal Health, Vaccines and Beef Prices	MT
Jan. 12	Zoetis Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 10:30 AM
Dec. 30	Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results	BU
Dec. 18	Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference	BU
Dec. 17	Morgan Stanley Adjusts Zoetis Price Target to $160 From $175, Maintains Overweight Rating	MT
Dec. 16	Sector Update: Health Care Stocks Edge Higher Premarket Tuesday	MT
Dec. 16	The Fed's Favorite Numbers?
Dec. 16	Zoetis Prices $1.75 Billion Convertible Notes Offering	MT
Dec. 16	Zoetis says co priced offering of $1.75 billion aggregate principal amount of 0.25% convertible senior notes due 2029	RE
Dec. 16	Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering	BU
Dec. 15	Zoetis to Offer $1.75 Billion Convertible Notes Offering	MT
Dec. 15	Zoetis announces proposed $1.75 billion convertible senior notes offering	RE
Dec. 15	BofA Securities Downgrades Zoetis to Neutral From Buy	MT
Dec. 15	Zoetis shares fall 2.6% premarket after co announces proposed $1.75 billion convertible senior notes offering	RE
Dec. 15	Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering	BU
Dec. 11	Zoetis Ups Quarterly Dividend to $0.53 per Share, Payable Mar. 3 to Holders of Record on Jan. 20	MT
Dec. 11	Zoetis declares first quarter 2026 dividend; board approves 6% payment increase	RE
Dec. 11	Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase	BU
Dec. 11	Zoetis Inc. Declares Dividend for the First Quarter of 2026, Payable on March 3, 2026	CI
Dec. 10	HSBC Adjusts Zoetis Price Target to $140 From $180, Maintains Buy Rating	MT
Dec. 09	Barclays Initiates Zoetis at Equalweight With $136 Price Target	MT
Dec. 08	Zoetis Receives Health Canada Approval for Portela to Alleviate Pain Associated with Osteoarthritis in Cats	AQ
Dec. 05	Zoetis Says Health Canada Approves Long-Lasting Cat Osteoarthritis Drug	MT
Dec. 05	Zoetis Inc. Receives Health Canada Approval for Portela?? (Relfovetmab Injection) to Alleviate Pain Associated with Osteoarthritis in Cats	CI
Dec. 05	Zoetis receives Health Canada approval for Portela (Relfovetmab injection)	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Zoetis CEO on Animal Health, Vaccines and Beef Prices

January 12, 2026 at 05:26 pm EST

Zoetis returns to reasonable valuation multiples

September 25, 2025 at 04:23 am EDT